authors
- Spector, Nelson
- Leber, Brian
- Lipton, Jeffrey Howard
- De Souza, Carmino
- Moiraghi, Beatriz
- Steegmann, Juan Luis
- Schwarer, Anthony P
- Cervantes, Francisco
- Hughes, Timothy P
- Purkayastha, Das
- Collins, LaTonya R
- Szczudlo, Tomasz K
- Rea, Delphine
Switching patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) with residual disease on long-term imatinib (IM) to nilotinib (NIL): ENESTcmr 24-mo follow-up
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2013
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal